Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
Journal of the National Cancer Institute
|
October 25, 2016
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer
Gabriele Picco, Consalvo Petti, Francesco Sassi, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 2, 2022
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway
Margherita Pergolizzi, Laura Bizzozero, Federica Maione, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2017
A Molecularly Annotated Model of Patient-Derived Colon Cancer Stem-Like Cells to Assess Genetic and Nongenetic Mechanisms of Resistance to Anti-EGFR Therapy
Paolo Luraghi, Viola Bigatto, Elia Cipriano, et al.
Cancers
|
June 12, 2020
Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles
Claudio Isella, Marco Vaira, Manuela Robella, et al.
BMC Cancer
|
July 5, 2018
FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients
Nelson Rangel, Nicoletta Fortunati, Simona Osella-Abate, et al.
Translational Oncology
|
June 29, 2012
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer
Laura Annaratone, Caterina Marchiò, Tommaso Renzulli, et al.
Nature Communications
|
June 1, 2017
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer
Claudio Isella, Francesco Brundu, Sara E Bellomo, et al.
Science Translational Medicine
|
January 30, 2015
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies
Eugenia R Zanella, Francesco Galimi, Francesco Sassi, et al.
Clinical Colorectal Cancer
|
April 15, 2019
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology
Giorgio Corti, Alice Bartolini, Giovanni Crisafulli, et al.
The Journal of Pathology
|
February 8, 2018
Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies
Matthew Alderdice, Susan D Richman, Simon Gollins, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
Journal of the National Cancer Institute
|
October 25, 2016
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer
Gabriele Picco, Consalvo Petti, Francesco Sassi, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 2, 2022
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway
Margherita Pergolizzi, Laura Bizzozero, Federica Maione, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2017
A Molecularly Annotated Model of Patient-Derived Colon Cancer Stem-Like Cells to Assess Genetic and Nongenetic Mechanisms of Resistance to Anti-EGFR Therapy
Paolo Luraghi, Viola Bigatto, Elia Cipriano, et al.
Cancers
|
June 12, 2020
Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles
Claudio Isella, Marco Vaira, Manuela Robella, et al.
BMC Cancer
|
July 5, 2018
FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients
Nelson Rangel, Nicoletta Fortunati, Simona Osella-Abate, et al.
Translational Oncology
|
June 29, 2012
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer
Laura Annaratone, Caterina Marchiò, Tommaso Renzulli, et al.
Nature Communications
|
June 1, 2017
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer
Claudio Isella, Francesco Brundu, Sara E Bellomo, et al.
Science Translational Medicine
|
January 30, 2015
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies
Eugenia R Zanella, Francesco Galimi, Francesco Sassi, et al.
Clinical Colorectal Cancer
|
April 15, 2019
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology
Giorgio Corti, Alice Bartolini, Giovanni Crisafulli, et al.
The Journal of Pathology
|
February 8, 2018
Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies
Matthew Alderdice, Susan D Richman, Simon Gollins, et al.
Page
of 7